About Dr. Nina Bayerl (née Schäffner)
Nina's area of expertise includes IP law and competition law, with special focus on the fields of life sciences, telecommunication and semiconductor technology.
In particular, she advises clients in complex and contentious patent litigation as well as on IP related questions within international transactions. Furthermore, Nina focuses on the intersection of competition and IP law, which includes the advice on the assertation of standard-essential patents. She also advises on all forms of contracts dealing with IP rights.
Before joining Freshfields, Nina wrote a doctoral thesis on patent strategies within the pharmaceutical sector at the Max Planck Institute for Innovation and Competition as a scholarship holder.
Nina speaks German and English.
- Acting for the Novartis group in several patent infringement matters, including enforcing second medical use patents for the blockbuster Glivec and enforcing a composition patent for Ritalin against several competitors.
- Representing several pharmaceutical companies in complex biotech entitlement proceedings.
- Advising major manufacturers in the telecoms industry with regard to enforcing of standard esential patents on a worldwide basis, including negotiation of respecive license agreements.
- Representing Lenovo in patent litigation relating to H.264 video decoding patents.
- Representing Facebook against BlackBerry in proceedings concerning several functionalities in apps.
- Advising several clients of the pharmaceutical and biotech industries on R&D cooperation agreements.
- Ludwig Maximilians University of Munich, Germany (law studies)
- University of Augsburg, Germany (doctoral of law)
- Attorney at law, Germany
- Member of the German Association of Intellectual Property (GRUR)